Source: Health Canada shortage reports · Updated Oct 29, 2026
Tinzaparin has no current shortage reported in Canada. It has been in shortage before; the history is below.
A low molecular weight heparin used to prevent and treat blood clots.
Products affected
0 / 11
Reports on file
20
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
INNOHEP
20000UNIT · SOLUTION · LEO PHARMA INC
DIN 02229515 · ended Oct 28, 2026 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
10000UNIT · SOLUTION · LEO PHARMA INC
DIN 02167840 · ended Aug 6, 2026 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
20000UNIT · SOLUTION · LEO PHARMA INC
DIN 02229515 · ended Jun 16, 2026 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
16000UNIT · SOLUTION · LEO PHARMA INC
DIN 02429489 · ended Apr 22, 2020 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
12000UNIT · SOLUTION · LEO PHARMA INC
DIN 02429470 · ended Apr 22, 2020 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
10000UNIT · SOLUTION · LEO PHARMA INC
DIN 02229755 · ended Apr 8, 2020 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
10000UNIT · SOLUTION · LEO PHARMA INC
DIN 02358166 · ended Mar 9, 2020 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
10000UNIT · SOLUTION · LEO PHARMA INC
DIN 02358158 · ended Mar 6, 2020 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
10000UNIT · SOLUTION · LEO PHARMA INC
DIN 02167840 · ended Jan 31, 2020 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
20000UNIT · SOLUTION · LEO PHARMA INC
DIN 02231478 · ended Dec 24, 2019 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
12000UNIT · SOLUTION · LEO PHARMA INC
DIN 02429470 · ended Dec 24, 2019 · Disruption of the manufacture of the drug.
Resolved
INNOHEP
20000UNIT · SOLUTION · LEO PHARMA INC
DIN 02358182 · ended Dec 19, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 20 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Tinzaparin. Health Canada has 20 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Tinzaparin is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AB).
Recent changes
Oct 29, 2026
Shortage resolved
Oct 27, 2026
Status changed
Sep 23, 2026
Shortage resolved
Aug 7, 2026
New report filed
Aug 6, 2026
Status changed
Jul 10, 2026
New report filed
Jul 10, 2026
Shortage resolved
Common questions
What is Tinzaparin used for?
A low molecular weight heparin used to prevent and treat blood clots.
When will Tinzaparin be back in stock in Canada?
Tinzaparin has no active shortage; supply is normal per Health Canada reports.
Why is Tinzaparin in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.